SH2B3, Transcribed by STAT1, Promotes Glioblastoma Progression Through Transducing IL-6/gp130 Signaling to Activate STAT3 Signaling
Glioblastoma (GBM) is the most common and aggressive brain tumor in adults. The aberrant activation of STAT3 commonly occurs in GBM and is a key player in GBM tumorigenesis. Yet, the aberrant activation of STAT3 signaling is not fully understood. Here, we report that SH2B adaptor protein 3 (SH2B3) i...
Main Authors: | Shan Cai, Jian-xiang Lu, Yan-pei Wang, Chao-jia Shi, Tian Yuan, Xiang-peng Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-04-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2021.606527/full |
Similar Items
-
STAT3 Activation in Glioblastoma: Biochemical and Therapeutic Implications
by: Jennifer E. Kim, et al.
Published: (2014-02-01) -
The Role and Therapeutic Targeting of JAK/STAT Signaling in Glioblastoma
by: Alexander Ou, et al.
Published: (2021-01-01) -
The role of p-Stat3 Y705 immunohistochemistry in glioblastoma prognosis
by: Sergiu Susman, et al.
Published: (2019-11-01) -
TROY signals through JAK1-STAT3 to promote glioblastoma cell migration and resistance
by: Zonghui Ding, et al.
Published: (2020-09-01) -
Roles of STAT3 in the pathogenesis and treatment of glioblastoma
by: Weijia Fu, et al.
Published: (2023-02-01)